The global microfluidic devices market was valued at USD 24.15 Billion in 2025, driven by the increasing prevalence of infectious and chronic diseases across the globe. The market is anticipated to grow at a CAGR of 7.80% during the forecast period of 2026-2035 to achieve a value of USD 51.18 Billion by 2035.
Base Year
Historical Period
Forecast Period
The growing demand for personalised medicine is driving the microfluidic devices market, as these technologies enable precise, rapid diagnostics and treatment delivery, improving patient outcomes and reducing healthcare costs.
Advancements in lab-on-a-chip technologies are poised to revolutionise the microfluidic devices market, offering cost-effective, portable solutions for diagnostics, drug discovery, and disease monitoring, expanding their use in healthcare.
Increasing investments in healthcare innovation and demand for point-of-care diagnostics are propelling the microfluidic devices market, enhancing the adoption of these devices for real-time, accurate medical testing.
Compound Annual Growth Rate
7.8%
Value in USD Billion
2026-2035
*this image is indicative*
Microfluidic devices are miniaturised systems that manipulate small amounts of fluids, typically in the microlitre or nanolitre range, through micro-channels. These devices are designed to perform precise analyses or reactions, commonly used in medical diagnostics, drug delivery, and chemical analysis. They offer advantages such as reduced sample size, faster processing times, and lower costs compared to traditional methods. Microfluidic devices enable high-throughput screening, real-time monitoring, and integration of multiple functions in a single platform, revolutionising healthcare, research, and environmental monitoring applications. Their growing adoption is driven by advances in technology and the demand for efficient, portable systems.
Surge in Investments to Bolster Market Growth
The increasing adoption of microfluidic technologies in diagnostics, drug discovery, and precision medicine is a key driver of the microfluidic devices market. For instance, In November 2024, Parallel Fluidics raised USD 7M in a seed round, supported by J2 Ventures, 8VC, and Praxis. The funds will support the growth of its on-demand design and manufacturing platform, enabling the company to scale its solutions and commercialise its innovative MV-2 product. Microfluidics enables life science companies to run precise tests at microscopic scales, enhancing precision, speed, and throughput. As more industries, such as sequencing, cell therapy, and diagnostics, adopt microfluidic technology, the market is expected to experience significant growth in the forecast period.
Microfluidic Innovations in Gene Therapy to Enhance Microfluidic Devices Market Demand
The increasing demand for precision gene and cell therapies drives growth in the microfluidic devices market. For instance, in May 2024, Takara Bio USA, Inc. launched the Lenti-X Transduction Sponge, a dissolvable microfluidic transduction enhancer designed to improve in vitro lentivirus-mediated gene delivery techniques. The sponge, with its easy workflow, enables high transduction efficiency across various cell types, facilitating further research in the gene and cell therapy space. This breakthrough innovation highlights the role of microfluidics in advancing gene and cell therapy applications. The successful adoption of such technologies is set to fuel the market's expansion in the coming years, particularly within biopharmaceutical applications.
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
"Microfluidic Devices Market Report and Forecast 2026-2035” offers a detailed analysis of the market based on the following segments:
Market Breakup by Type of Microfluidic Device
Market Breakup by Material
Market Breakup by Technology
Market Breakup by End User
Market Breakup by Region
Lab-on-a-Chip Devices to Dominate by Type
Lab-on-a-Chip (LoC) devices are expected to hold the largest market share due to their wide application in diagnostics, drug development, and personalised medicine. Their ability to miniaturise laboratory functions into a single chip makes them cost-effective, time-efficient, and accurate, driving their demand. The growing trend towards point-of-care diagnostics and personalised treatment will further propel LoC devices' adoption. With advancements in technology and an expanding number of research applications, LoC devices are well-positioned to lead the market, contributing to the growth of the overall microfluidic devices market.
Polymers to Hold a Substantial Microfluidic Devices Market Value for Segmentation by Material
Polymers are poised to dominate the microfluidic devices material segment due to their cost-effectiveness, versatility, and ease of manufacturing. Polymers offer several advantages over other materials, including flexible design options, the potential for mass production, and biocompatibility, making them ideal for lab-on-a-chip applications. Their widespread use in disposable devices further drives demand, particularly in point-of-care diagnostics and rapid testing solutions. As the microfluidic devices market continues to grow, the demand for polymer-based products will remain strong, providing significant opportunities for manufacturers to expand their production and meet increasing market requirements.
Active Microfluidics to Lead Microfluidic Devices Market Segmentation by Technology
Active microfluidics is expected to hold the largest market share in the technology segment due to its ability to control fluid flow actively, offering higher precision and versatility. This technology allows for better manipulation of fluids, enabling complex applications in diagnostics, drug delivery, and lab-on-a-chip systems. Active microfluidic devices also benefit from ongoing innovations in sensors and actuators, which enhance their performance. The demand for more sophisticated and efficient microfluidic systems, especially in pharmaceutical and healthcare applications, will propel the growth of active microfluidics in the forecast period.
Pharmaceutical and Biotechnology Companies to Dominate Microfluidic Devices Market by End User
Pharmaceutical and biotechnology companies are expected to dominate the end-user segment of the market. The growing focus on drug development, personalised medicine, and high-throughput screening in these industries drives demand for advanced microfluidic technologies. These devices offer precision, scalability, and efficiency, critical for drug discovery and development processes. Additionally, microfluidic devices enable better reproducibility and cost reduction in laboratory workflows. As pharmaceutical companies continue to invest in research and development, their reliance on microfluidic devices for innovation and efficiency will fuel substantial market growth in the forecast period.
North America is poised to hold the largest share of the microfluidic devices market due to its strong biotechnology and pharmaceutical industries, extensive R&D investments, and a well-established regulatory framework. The presence of leading industry players and the rising adoption of microfluidics in point-of-care diagnostics further drive regional growth. Europe follows closely, supported by advancements in lab-on-a-chip technology and government funding for biomedical research. Asia Pacific is experiencing rapid growth due to increasing healthcare demand and local manufacturing capabilities. Latin America and the Middle East & Africa have emerging markets, but limited infrastructure and slower adoption rates hinder their market share expansion in the forecast period.
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Thermo Fisher Scientific Inc., headquartered in Waltham, Massachusetts, was established in 2006 following the merger of Thermo Electron and Fisher Scientific. The company is a global leader in scientific research solutions, including microfluidic devices for diagnostics, drug development, and life sciences applications. Its portfolio includes lab-on-a-chip technologies, microfluidic cartridges, and analytical systems that enhance precision and automation in molecular testing. With a strong presence in research and clinical diagnostics, Thermo Fisher continues to drive advancements in microfluidics, enabling high-throughput analysis and personalised medicine solutions for various industries.
Founded in 1937, PerkinElmer, Inc. is headquartered in Waltham, Massachusetts, and specialises in analytical and life science solutions. The company offers microfluidic devices designed for applications in genomics, proteomics, and clinical diagnostics. Its portfolio includes automated microfluidic systems for high-throughput screening, point-of-care testing, and drug discovery. PerkinElmer's expertise in assay development and lab automation strengthens its position in precision medicine and disease research. Through continuous innovation, the company enhances microfluidics for rapid diagnostics and personalised healthcare, supporting pharmaceutical and biotechnology industries worldwide.
Darwin Microfluidics, a subsidiary of Becton, Dickinson and Company (BD), is a leading provider of microfluidic solutions headquartered in France. Since its founding, the company has specialised in designing and distributing microfluidic chips, pumps, and accessories for research and industrial applications. Darwin Microfluidics offers customised lab-on-a-chip platforms and organ-on-chip technologies for biomedical, pharmaceutical, and environmental studies. With BD’s acquisition, the company benefits from expanded resources and expertise, strengthening its global presence in microfluidic device innovation and supporting applications in diagnostics, drug development, and synthetic biology.
Established in 1999 as a spin-off from Hewlett-Packard, Agilent Technologies Inc. is headquartered in Santa Clara, California. The company is a key player in life sciences, diagnostics, and applied chemical markets, offering advanced microfluidic devices for chromatography, mass spectrometry, and lab automation. Agilent’s microfluidic portfolio includes electrophoresis chips, bioanalyzers, and liquid-handling systems that enhance precision in genomics, proteomics, and cell analysis. The company’s continued advancements in microfluidics enable high-throughput screening and automated workflows, driving progress in personalised medicine, environmental testing, and biopharmaceutical research worldwide.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, DH Life Sciences, LLC., Illumina, Inc., IDEX Corporation, and Fluidigm Corporation.
Upto 15% Off
USD
$5499 $4949
$3299 $2969
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type of Microfluidic Device |
|
| Breakup by Material |
|
| Breakup by Technology |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share